Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Heartport

This article was originally published in The Gray Sheet

Executive Summary

Heartport: Acquires Utah Biomedical Test Laboratory, which the Redwood City, California company plans to use as the principal U.S. training center for its Port-Access minimally invasive cardiac surgery. Training is scheduled to begin this quarter at the 50,000-square-foot surgical laboratory. The facility will enable Heartport to "centralize and accelerate its U.S. training activities" and to "substantially accelerate and broaden its research and development activities," the firm says. On Oct. 7, Heartport received FDA clearance for the EndoCPB catheter system to perform Port-Access coronary artery bypass grafting and other cardiac surgeries. Heartport plans to launch the system by mid-1997 following physician training ("The Gray Sheet" Oct. 14, I&W-1)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006999

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel